Proceeding contribution from Lord Lansley (Conservative) in the House of Commons on Thursday, 8 December 2005. It occurred during Estimates day on Department of Health.
Department of Health
Does my hon. Friend agree that although this matter is not covered in the Health Committee report, the mechanism for the approval of vaccinations and immunisations is still within the hands of the Department of Health and does not rest with National Institute for Health and Clinical Excellence? On TB testing, there is a very good case for examining the efficacy of the old technology for skin tests compared with new blood-testing technologies, and I have asked questions about that matter. At the moment, the mechanism sits inside the DOH and vaccinations and immunisations are not exposed to an evidence-based appraisal by NICE.
Secondary information
- Type
- Proceeding contribution
- Reference
- 440 c1044-5
- Session
- 2005-06
- Chamber / Committee
- House of Commons chamber
- Subjects
- Advertising Licensing Expenditure Drugs Government departments Industry Prescription drugs Department of Health Medicines and Healthcare products Regulatory Agency Research Regulation Safety National Institute for Health and Care Excellence Registration Clinical trials
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2025-11-24 15:50:33 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285130
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285130
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285130